目的:为泻白散及其加减方的现代开发和应用提供参考。方法:以“泻白散”“临床应用”“Xiebai Powder”“Clinical application”等为关键词,在中国知网、万方数据、维普网、PubMed、Web of Science等数据库中组合查询1985-2019年4月发表的相关文献,对泻白散及其加减方的临床应用进行综述。结果与结论:共检索到相关文献265篇,其中有效文献37篇。泻白散及其加减方的临床应用较多,主要应用于治疗呼吸系统疾病、皮肤病、鼻病、小儿顽固性厌食症、肺癌等疾病,疗效较好;但泻白散成方的作用靶点尚未明确,研究机制大多集中在抗炎机制方面,研究内容相对局限。
The First School of Clinical Medicine,Gansu University of Chinese Medicine
Dept. of Integrated Traditional Chinese and Western Medical Rheumatology & Immunology,Gansu Provincial Hospital
College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Peking Union Medical College & Institute of Radiation Medicine, Chinese Academy of Medical Sciences
Shanghai Institute for Biomedical and Pharmaceutical Technologies/NHC Key Lab of Reproduction Regulation/Shanghai Engineer and Technology Research Center of Reproductive Health Drug and Devices